Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis.

Mark JansenSila AlgülLaurens P BosmanMichelle MichelsJolanda van der VeldenRudolf A de BoerJ Peter van TintelenFolkert W AsselbergsAnnette F Baas

Published in: ESC heart failure (2022)

Several blood-based biomarkers were identified as predictors of HCM outcomes. Additional studies are required to validate their prognostic utility within current risk stratification models.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
metabolic syndrome
adipose tissue
weight loss
glycemic control